Skip to content
MS
rate-limiting unreviewed

Glutamine-PRPP amidotransferase

1 reactions · 1 pathways

Cofactors used

Clinical / pharmacological. Committed step of purine synthesis; feedback-inhibited by AMP/GMP; azaserine site

What it does, reaction by reaction

1 reactions

Purine De Novo Synthesis (IMP synthesis through to AMP/GMP) Nucleotide Metabolism · Cytosol

step 2 Irreversible rate-limiting

PRPP → 5-phosphoribosylamine (5-PRA)

Converts PRPP into 5-Phosphoribosylamine

Notes

Glutamine-PRPP amidotransferase catalyzes PRPP + glutamine + H2O → 5-PRA + glutamate + PPi. The enzyme uses an internal glutaminase domain to generate ammonia, which is channeled to the phosphoribosyl-transferase domain; PPi hydrolysis drives the reaction forward. This is the committed, rate-limiting, and effectively irreversible step of de novo purine synthesis.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Purine De Novo Synthesis (IMP synthesis through to AMP/GMP)

Accelerated by

PRPP

Inhibited by

IMP, AMP, and GMP (feedback inhibition; combined nucleotide pools are most effective)

Hormonal control

No established direct endocrine regulation; expression/flux increase with growth signals and proliferation.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
  2. 2
    Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment.

    Singh NN, Ottesen EW, Singh RN. · 2026-05-25

    open access unreviewed
  3. 3
    Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance.

    Hitti E, Bakheet T, Mahmoud L, Al-Mutairi N, Alhaj L, Al-Zoghaibi F, Khabar KSA. · 2026-02-16

    open access unreviewed
  4. 4
  5. 5
    Cucurbitacin B targets PPAT to suppress de novo purine biosynthesis in esophageal squamous cell carcinoma.

    Jia H, Guo J, Luo H, Zhou X, Hou D, Khan A, Xue Y, Dai Z, Qiao Y, Song M, Dong Z. · 2026-06-03

    unreviewed
  6. 6
    Metabolite glues as a means of purine sensing and chemotherapeutic response.

    Witus SR, Kober MM, Roh H, Yang Z, Choueiry F, Ghate AS, Titov DV, Rapé M. · 2026-07-15

    unreviewed
  7. 7
    Tributyltin-dysregulated periprostatic adipose tissue enhances prostate cell survival and migration, implicating the C-C motif chemokine receptor 3.

    Feijó M, Casanova CR, Fonseca LRS, Figueira MI, Brás LA, Catarro G, Gallardo E, Kiss-Toth E, Correia S, Socor… · 2025-06-09

    unreviewed
  8. 8
    The intersection of race and adiposity in prostate cancer: a narrative review.

    Smith M, Lawen T, Garcia RS, Pyo J, Hahn A, Frigo D, Ma H, Wei P, Robert M, Chery L, Chapin BF, Daniel CR, Pe… · 2025-10-20

    unreviewed
  9. 9
  10. 10
    Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

    Manolakou T, Shen J, Boddul S, Samiotaki M, Panagias MA, Sentis G, Silva TA, Argyriou A, Nikolopoulos D, Sanj… · 2026-06-10

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.